D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: Prognostic and prescriptive variables.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of the current study was to identify individual characteristics that (a) predict symptom improvement with group cognitive behavioral therapy (CBT) for social anxiety disorder (SAD; i.e., prognostic variables) or (b) moderate the effects of d-cycloserine (DCS) versus placebo augmentation of CBT for SAD (i.e., prescriptive variables). METHOD: Adults with SAD (N = 169) provided Liebowitz Social Anxiety Scale scores in a trial evaluating DCS augmentation of group CBT. Rate of symptom improvement during therapy and posttreatment symptom severity were evaluated using multilevel modeling. As predictors of these 2 parameters, we selected the range of variables assessed at baseline (demographic characteristics, clinical characteristics, personality traits). Using step-wise analyses, we first identified prognostic and prescriptive variables within each of these domains and then entered these significant predictors simultaneously in 1 final model. RESULTS: African American ethnicity and cohabitation status were associated with greater overall rates of improvement during therapy and lower posttreatment severity. Higher initial severity was associated with a greater improvement during therapy but also higher posttreatment severity (the greater improvement was not enough to overcome the initial higher severity). DCS augmentation was evident only among individuals low in conscientiousness and high in agreeableness. CONCLUSIONS: African American ethnicity, cohabitation status, and initial severity are prognostic of favorable CBT outcomes in SAD. DCS augmentation appears particularly useful for patients low in conscientiousness and high in agreeableness. These findings can guide clinicians in making decisions about treatment strategies and can help direct research on the mechanisms of these treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420
Self-citationSchneier (1992) · doi:10.1001/archpsyc.1992.01820040034004 · Cited by 1,142
Hofmann, S. G. (2007) · Cognitive Behaviour Therapy · doi:10.1080/16506070701421313 · Cited by 1,064 · cited 2×
“…that patients presenting with severe generalized SAD, as defined by the presence of high symptom severity, do not respond more poorly to CBT emphasizing exposure to feared cues coupled with cognitive restructuring (Hofmann, 2007; Hofmann & Otto, 2008) relative to patients with less severe SAD.”
BackgroundMethodInfluentialSelf-citationCognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human
Soliman, F., Glatt, C. E., Bath, K. G., Levita, L., Jones, R. M., Pattwell, S. S., Jing, D., Tottenham, N., Amso, D., Somerville, L. H., et al. (2010) · Science · doi:10.1126/science.1181886 · Cited by 585 · cited 4×
“, 2009) and humans (Soliman et al., 2010), likely because of reduced ventromedial prefrontal activity and increased amygdala activity during extinction.”
BackgroundInfluentialAugmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560
Self-citationEffects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work
Davis, M., Ressler, K., Rothbaum, B. O., & Richardson, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.084 · Cited by 498 · cited 2×
“Following preclinical research demonstrating that DCS can facilitate extinction learning in rodents by enhancing NMDA receptor function (Davis et al., 2006), initial studies of DCS for augmenting exposure therapy for the anxiety disorders have yielded promising results (Bontempo, Panza, & Bloch, 2012).”
BackgroundPhenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444 · cited 4×
“This domain comprised clinical severity (as assessed by the Social Phobic Disorders Severity Form; SPD-SC; Liebowitz et al., 1992), depressive symptom severity (as assessed by the Montgomery Asberg Depression Rating Scale; MADRS (Montgomery & Asberg, 1979) and Axis I comorbidity (i.e., number of comorbid Axis I disord…”
MethodInfluentialFluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415 · cited 5×
“Indeed, treatment non-response rates in large clinical trials have been 50% or higher (Davidson et al., 2004), and most individuals do not achieve remission (Blanco et al., 2010; Davidson et al., 2004).”
BackgroundInfluentialFournier, J. C., DeRubeis, R. J., Shelton, R. C., Hollon, S. D., Amsterdam, J. D., & Gallop, R. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0015401 · Cited by 340 · cited 17×
“Race/Ethnicity—Given there was meaningful representation (≥10% of the sample (Fournier et al., 2009) of Hispanic, Asian, and African American patients, we compared non-Hispanic White to Hispanic White, African American, Asian and Other (i.”
BackgroundMethodInfluentialEfficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., & Pollack, M. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.036 · Cited by 251
Self-citationPredictors of Response to Cognitive-Behavioral Group Therapy for Social Phobia
Chambless, D. L., Tran, G. Q., & Glass, C. R. (1997) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00008-x · Cited by 228
de Kleine, R. A., Hendriks, G.-J., Kusters, W. J. C., Broekman, T. G., & van Minnen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.033 · Cited by 220 · cited 2×
“…that the DCS augmentation effects are indeed stronger for individuals for whom a standard course of CBT leaves ample room for improvement (see de Kleine et al., 2012), high agreeableness may also emerge as a prognostic and prescriptive variable in our analysis, as it has been associated with…”
BackgroundResultBlanco, C., Heimberg, R. G., Schneier, F. R., Fresco, D. M., Chen, H., Turk, C. L., Vermes, D., Erwin, B. A., Schmidt, A. B., Juster, H. R., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.11 · Cited by 206 · cited 1×
“Indeed, treatment non-response rates in large clinical trials have been 50% or higher (Davidson et al., 2004), and most individuals do not achieve remission (Blanco et al., 2010; Davidson et al., 2004).”
BackgroundComorbid anxiety and mood disorders among persons with social anxiety disorder
Erwin, B. A., Heimberg, R. G., Juster, H., & Mindlin, M. (2002) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00114-5 · Cited by 153 · cited 2×
“Several studies have, however, failed to observe the relation between depression and rate of change during CBT for SAD (Erwin et al., 2002; Joormann, Kosfelder, & Schulte, 2005; Turner et al., 1996), suggesting that baseline depression severity may simply be associated with greater symptom severity…”
ResultHofmann, S. G., Smits, J. A. J., Rosenfield, D., Simon, N., Otto, M. W., Meuret, A. E., Marques, L., Fang, A., Tart, C., & Pollack, M. H. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070974 · Cited by 121
Self-citationMcEvoy, P. M., Nathan, P., Rapee, R. M., & Campbell, B. N. C. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2012.01.009 · Cited by 60
The Impact of Comorbidity of Depression on the Course of Anxiety Treatments
Joormann, J., Kosfelder, J., & Schulte, D. (2005) · Cognitive Therapy and Research · doi:10.1007/s10608-005-3340-5 · Cited by 56
Cited by
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“…phobia (Guastella et al., 2007; Nave et al., 2012; Ressler et al., 2004), SAD (Guastella et al., 2008; Hofmann et al., 2006; Hofmann et al., 2013b; Smits et al., 2013c) and OCD [(Chasson et al., 2010; Farrell et al., 2013; Kushner et al., 2007; Storch et al., 2010; Wilhelm et al., 2008) but see…”
BackgroundMethodInfluentialLeigh, H. (2015) · Handbook of Consultation-Liaison Psychiatry · doi:10.1007/978-3-319-11005-9_14 · Cited by 309
Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data
Powers, M. B., Medina, J. L., Burns, S., Kauffman, B. Y., Monfils, M., Asmundson, G. J. G., Diamond, A., McIntyre, C., & Smits, J. A. J. (2015) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2015.1012740 · Cited by 194
“Since then, a number of clinical trials (e.g. Hofmann et al., 2013; Smits et al., 2013; Smits et al., 2013; Tart et al., 2013) have replicated and extended these findings to other anxiety disorder samples (Rodrigues et al., 2014).”
BackgroundOlatunji, B. O., Kauffman, B. Y., Meltzer, S., Davis, M. L., Smits, J. A. J., & Powers, M. B. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.05.002 · Cited by 167
Self-citationSchneider, R. L., Arch, J. J., & Wolitzky-Taylor, K. B. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.004 · Cited by 135
Metadata
- Authors
- Smits, J. A. J., Hofmann, S. G., Rosenfield, D., DeBoer, L. B., Costa, P. T., Simon, N. M., O'Cleirigh, C., Meuret, A. E., Marques, L., Otto, M. W., & Pollack, M. H.
- Venue
- Journal of Consulting and Clinical Psychology
- Published
- 2013
- Volume
- 81
- Issue
- 6
- Pages
- 1100-1112
- ISSN
- 0022-006X (ISSN-L)
- 1939-2117
- OpenAlex
- W2047811508
- Cited by
- 46
- References
- 20
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.